Van Hulzen Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.92M Buy
2,088
+266
+15% +$270K 0.14% 102
2025
Q4
$1.96M Sell
1,822
-78
-4% -$74.6K 0.14% 107
2025
Q3
$1.45M Sell
1,900
-388
-17% -$289K 0.11% 126
2025
Q2
$1.78M Sell
2,288
-65
-3% -$50.5K 0.15% 108
2025
Q1
$1.94M Buy
2,353
+9
+0.4% +$7.49K 0.18% 105
2024
Q4
$1.81M Buy
2,344
+127
+6% +$105K 0.13% 125
2024
Q3
$1.96M Buy
2,217
+56
+3% +$50.3K 0.14% 122
2024
Q2
$1.96M Buy
2,161
+49
+2% +$39.2K 0.13% 111
2024
Q1
$1.64M Sell
2,112
-1
-0% -$712 0.11% 129
2023
Q4
$1.23M Buy
2,113
+28
+1% +$16.3K 0.09% 140
2023
Q3
$1.12M Sell
2,085
-4,561
-69% -$2.35M 0.09% 142
2023
Q2
$3.12M Buy
6,646
+797
+14% +$334K 0.27% 73
2023
Q1
$2.01M Buy
5,849
+4,556
+352% +$1.54M 0.19% 85
2022
Q4
$473K Buy
+1,293
New +$458K 0.05% 182
2015
Q3
Sell
-2,521
Closed -$210K 159
2015
Q2
$210K Sell
2,521
-7,028
-74% -$536K 0.11% 133
2015
Q1
$694K Sell
9,549
-2,441
-20% -$174K 0.42% 66
2014
Q4
$827K Buy
11,990
+1,565
+15% +$106K 0.57% 48
2014
Q3
$676K Buy
+10,425
New +$660K 0.69% 47

Other funds holding LLY

Van Hulzen Asset Management's LLY Position: Q1 2026 in Review

Van Hulzen Asset Management increased its Eli Lilly (LLY) stake by 15% in Q1 2026, buying an estimated $270K and bringing the position to 2,088 shares worth $1.92M. The position accounts for 0.14% of the portfolio, ranked #102.

Van Hulzen Asset Management first reported a position in LLY in Q3 2014 and has held it in 18 quarters since. The position peaked at $3.12M in Q2 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Van Hulzen Asset Management held 2,088 shares of Eli Lilly worth $1.92M as of Q1 2026.
  • Van Hulzen Asset Management bought 266 Eli Lilly shares in Q1 2026, an estimated $270K.
  • Eli Lilly made up 0.14% of Van Hulzen Asset Management's portfolio in Q1 2026, its #102 holding.
  • Van Hulzen Asset Management first reported a position in Eli Lilly in Q3 2014 and has held it in 18 quarters since.
  • Van Hulzen Asset Management's Eli Lilly position peaked at $3.12M in Q2 2023.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Van Hulzen Asset Management's 13F filing for Q1 2026, filed 14 May 2026.